ATS Corporation: Positioned For Margin Expansion And Steady Organic Growth

Q3’26 recap: 16.7% revenue growth, $2.05B backlog, margin upside, and attractive valuation. Read here for more analysis.
Business Insider

Praxis Precision Medicines Further Positioned for Next-Phase Growth with Key Board and Executive Appointments

BOSTON, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for ...
Hosted on MSN

Ensysce Biosciences CEO says 'positioned for continued momentum'

Ensysce Biosciences (ENSC) issued its 2025 annual letter to shareholders from CEO Lynn Kirkpatrick, which read in part, “2025 was a year of meaningful execution and strategic advancement for Ensysce.
Business Insider

GlobalTech Horizons Asia (GTH-Asia) Concludes 2025 Preparation Phase and Enters 2026 Positioned to Evaluate Up to USD 100 Million in Structured Capital Execution Across ...

Singapore, Jan. 12, 2026 (GLOBE NEWSWIRE) -- GlobalTech Horizons Asia (GTH-Asia) , in collaboration with JYSigma Business Consultancy , has concluded its 2025 preparation and foundation phase and ...
MarketWatch

GlobalTech Horizons Asia (GTH-Asia) Concludes 2025 Preparation Phase and Enters 2026 Positioned to Evaluate Up to USD 100 Million in Structured Capital Execution Across ...

The MarketWatch News Department was not involved in the creation of this content. Singapore, Jan. 12, 2026 (GLOBE NEWSWIRE) -- GlobalTech Horizons Asia (GTH-Asia), in collaboration with JYSigma ...